Tag: FDA

FDA: Class I recall of Medtronic implantable cardioverter, cardiac resynchronization therapy defibrillators

Editor's Note The Food and Drug Administration (FDA), on July 18, identified the recall by Medtronic of its implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds) as Class I, the most serious. Medtronic is recalling all ICDs and CRT-Ds, with glassed feedthroughs that were manufactured after 2017, as…

Read More

By: Judy Mathias
July 18, 2023
Share

FDA: Class I recall of Draeger Medical’s Oxylog 3000 Plus Emergency and Transport Ventilators

Editor's Note The Food and Drug Administration (FDA), on July 13, identified the recall by Draeger Medical of its Oxylog 3000 Plus Emergency and Transport Ventilators as Class I, the most serious. The recall was initiated because of reports that the ventilator may not automatically switch back to using AC…

Read More

By: Judy Mathias
July 14, 2023
Share

FDA: Class I recall of Megadyne’s Mega 2000, Mega Soft reusable patient return electrodes

Editor's Note The Food and Drug Administration (FDA), on July 11, identified the recall by Megadyne of its Mega 2000 and Mega Soft reusable patient return electrodes as Class I, the most serious. The recall was initiated after Megadyne received reports of pediatric and adult patients receiving burn injuries during…

Read More

By: Judy Mathias
July 11, 2023
Share

ASA suggests patients stop popular weight loss medications before elective surgery

Editor's Note The American Society of Anesthesiologists (ASA) announced on June 29 that patients taking any of the currently popular medications for weight loss or for the treatment of type 2 diabetes should withhold the medication prior to elective surgery to "reduce the risk of complications associated with anesthesia in…

Read More

By: Tarsilla Moura
July 5, 2023
Share

FDA: Class I recall of Arrow Endurance Extended Dwell Peripheral Catheter System

Editor's Note The Food and Drug Administration (FDA), on June 26, identified the recall by Teleflex, and their subsidiary Arrow International, of the Arrow Endurance Extended Dwell Peripheral Catheter System as Class I, the most serious. The recall was initiated because of the risk of catheter separation and leakage. If…

Read More

By: Judy Mathias
June 27, 2023
Share

Pfizer warns FDA of penicillin shortage

Editor's Note Pfizer alerted the Food and Drug Administration (FDA) on June 12 that its supply of two forms of injectable penicillin—Bicillin L-A and Bicillin C-R—may run out by the end of this month, the June 13 The Hill reports. Pfizer cited a combination of factors for the shortage, including…

Read More

By: Judy Mathias
June 15, 2023
Share

FDA: Class I recall of Walnut Wearable Smart Thermometers

Editor's Note The Food and Drug Administration, on June 12, identified the recall of the rechargeable Walnut Wearable Smart Thermometer as Class I, the most serious. BearCare, Inc, is recalling the thermometers after receiving reports of skin burns and irritation resulting from use of the device. The company reports five…

Read More

By: Judy Mathias
June 14, 2023
Share

FDA letter on supply shortage of nonsterile, single-use pneumatic tourniquet cuffs

Editor's Note In a June 5 letter to healthcare providers, the Food and Drug Administration (FDA) says it is aware of US healthcare facilities and providers experiencing supply constraints of nonsterile, single-use pneumatic tourniquet cuffs. The cuffs are used in elective limb surgeries and in emergency and trauma settings. During…

Read More

By: Judy Mathias
June 12, 2023
Share

FDA: Class I recall of specific Abiomed Impella 5.5 with SmartAssist heart pumps

Editor's Note The Food and Drug Administration (FDA), on June 5, identified the recall by Abiomed of specific Impella 5.5 with SmartAssist heart pumps as Class I, the most serious. The recall was initiated because of fluid leaking from the purge sidearm of the pump. If the leak issue is…

Read More

By: Judy Mathias
June 5, 2023
Share

FDA: Class I recall of certain SD BioSensor Pilot COVID-19 At-Home Tests

Editor's Note The Food and Drug Administration (FDA), on May 25, identified the recall by SD BioSensor, Inc, of certain Pilot COVID-19 At-Home Tests as Class I, the most serious. The recall was initiated because the liquid solution in the test kit may be contaminated with bacteria such as Enterococcus,…

Read More

By: Judy Mathias
May 30, 2023
Share
Live chat by BoldChat